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The preferred ligands for the Hck Src homology 2 domain among a combinatorial library
containing 324 different peptides were determined in a single experiment involving Fourier
transform ion cyclotron resonance (FT-ICR) mass spectrometry (MS), electrospray ionization
(ESI), stored-waveform inverse Fourier transformation (SWIFT), and infrared multiphoton
laser disassociation (IRMPD). These were compared with the results obtained by conventional
screening of the peptide library in solution using affinity chromatography. The results
reported here show that by combining ESI, FT-ICR MS, SWIFT, and IRMPD, ligands likely to
bind under physiological conditions are rapidly and efficiently identified, even from complex
library mixtures. In the gas phase some discrimination against hydrophobic ligands could be
observed. However, the illustrated feasibility of identifying high affinity ligand via gas-phase
screening of complex library mixtures should lead to broad applications in the development of
ligands for proteins with interesting biological activity, the first step that must be taken to
develop a therapeutic agent. (J Am Soc Mass Spectrom 2002, 13, 1162–1169) © 2002 American
Society for Mass Spectrometry
A variety of innovations has permitted massspectrometry (MS) to expand its scope beyondsmall organic molecules to encompass biologi-
cal macromolecules, including proteins and nucleic
acids [1, 2]. Fourier transform ion cyclotron resonance
(FT-ICR) mass adds unique features to the possibilities
of mass spectrometric characterization of biomolecules
[3]. It allows the observation of ions of high molecular
weight proteins at ultra high resolution and high mass
accuracy.
Important in the application of FT-ICR methods to
biological macromolecules are “soft” ionization tech-
niques, which generate macromolecular ions without
fragmentation. Electrospray ionization (ESI) and ma-
trix-assisted laser desorption/ionization (MALDI) are
two of these [4, 5]. ESI involves spraying an aqueous
solution of a biological macromolecule under “quasi-
physiological” conditions directly into a mass spec-
trometer. The solvent evaporates in the vacuum from
the droplets, gently “elevating” a biological ion from its
native environment in solution. This process frequently
leaves non-covalent macromolecular complexes intact
and allows the mass spectrometric observation of en-
zyme-substrate, receptor-ligand, peptide-peptide, pro-
tein-subunit, oligonucleotide-toxin/drug, and DNA
duplex binding in the gas phase [6].
In many cases, binding constants estimated from
mass spectrometric studies match the binding constants
obtained in solution to within an order of magnitude
[7]. The gentleness of ESI allows H/D exchange exper-
iments in the gas phase to give information about
protein conformation and protein/protein interactions
based on measurements of the exchange rates of protein
backbone amide protons [8, 9]. This combination of
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delicate handling of sensitive biological macromole-
cules and high resolution mass spectrometry now has
the potential to yield insight into ongoing biological
activity [10, 11].
ESI combined with FT-ICR MS might be applied to
detect complexes between biological macromolecules
and ligands selected from a library of smaller organic
molecules. In principle, the complex between the mac-
romolecular receptor and the preferred ligand can be
detected directly by FT-ICR MS, and a single experi-
ment can determine the mass of the molecule that has
the highest affinity for the receptor from a (potentially)
large number of small organic molecules. If the ligand
can be subsequently released from the complex and
itself analyzed by mass spectrometry, it might be pos-
sible to determine the structure of the tightest ligand for
a receptor from a library of candidate receptors without
the need of solution-phase separation procedures. Non-
specific binding should be less problematic when using
ligand mixtures [7], because competitive-binding con-
ditions are an intrinsic property of combinatorial library
screening and high-affinity ligands are expected to
displace low-affinity ligands from the binding pocket
(when present in comparable amounts).
A pilot demonstration of the screening of a highly
degenerate combinatorial library by isolation and iden-
tification of non-covalent complexes in the gas phase
has been published [12]. Nevertheless, the limitations of
the mass spectrometric technique are not yet well
defined, and comparison of solution phase and gas-
phase protein structure and reactivity has just begun
[13]. The value of such an approach to the development
of pharmaceutical agents is apparent.
We report here an implementation of this approach
to identify the preferred ligands for Src homology 2
(SH2) domains. SH2 domains are non-catalytic
polypeptides 100 amino acids in length. They were
originally defined in the Src family of phosphotyrosine
kinases, and disturbance of the complex signaling cas-
cades severely affects principal cellular functions. Al-
teration or loss of the function of an SH2 domain is
frequently associated with cell transformation and can-
cer.
SH2 domains are found as modules in a variety of
proteins, including phospholipase C-, GTPase activat-
ing protein, phosphatidylinositol 3'-kinase, and many
other systems involved in signal transduction pathways
[14]. Their primary binding specificity is to phosphor-
ylated tyrosine. Different SH2 domains have differing
specificities for the surrounding peptide sequence,
however, and this secondary binding specificity is re-
sponsible for the distinctive biological properties of
each SH2 domain [15, 16].
The hematopoietic cell kinase (Hck) SH2 domain is a
member of the Src SH2 subfamily of cellular tyrosine
kinases [17, 18]. It is preferentially expressed in myeloid
and B-lymphoid cells and is bound to B-cell receptors in
unstimulated B cell lineages. Recent studies on Hck SH2
domain suggested a new role for SH2 domains as
intramolecular positioning tools for SH3 domains and
entailed a reevaluation of the importance of SH2 and
SH3 domains in the process of intermolecular signal
transduction [19, 20].
Here, we report the screening of Hck SH2 domain
with a 324-member combinatorial peptide library using
gas phase screening via non-covalent complex forma-
tion in comparison with conventional affinity-based
screening, which has not been done to date with a
library of this size. The non-covalent complexes be-
tween this SH2 domain and the preferred phospho-
peptide ligands were identified by use of the ESI
technique to generate ions, FT-ICR MS joined with the
stored-waveform inverse Fourier transform (SWIFT)
technique to trap and isolate the non-covalent complex,
and subsequent IRMPD-irradiation to release the pre-
ferred binding ligands [21, 22]. We then compare and
discuss the gas-phase results in terms of those derived
from conventional screening assays.
Experimental
Synthesis of a Degenerate Peptide Library
A peptide library having the general formula Ac-GpY-
EXX-ethylenediamine (Eda) (where X is any of 18 amino
acids), was synthesized on diaminoethanetrityl resin
(345 mg, 0.1 mmol) (Novabiochem) by use of the
Fmoc/tBu orthogonal protection strategy and standard
HBTU/HOBt/DIEA activation procedure with piperi-
dine deprotection [23–26]. Yields were ca. 90%. The
degenerate positions, indicated by “X” in the general
sequence, were synthesized by successive coupling of
an equimolar mixture (“cocktail”) of protected Fmoc
amino acids by means of the “mixture coupling ap-
proach” described elsewhere and the above standard
solid-phase peptide synthesis protocols [27]. The Fmoc
amino acid cocktail was made by dissolving the (eigh-
teen) weighed amino acids, FmocAlaOH, FmocArg(Pb-
f)OH, FmocAsn(Trt)OH, FmocAsp(tBu)OH, FmocGln-
(Trt)OH, FmocGlu(tBu)OH, FmocGlyOH, FmocHis
(Trt)OH, FmocIleOH, FmocLys(Boc)OH, FmocPheOH,
FmocSer(tBu)OH, FmocThr(tBu)OH, FmocTrp(Boc)OH,
FmocTyr(tBu)OH, FmocValOH, FmocProOH, and Fmoc-
MetOH, in DMF to a final concentration of 0.2 mmol/mL.
Cys and Leu were omitted from the cocktail, for a total
library of 18  18  324 peptides.
After the two degenerate amino acids were coupled
to the resin, FmocGlu(OtBu)OH (255 mg, 0.6 mmol) was
coupled to H-Xxx-Xxx-diaminoethane-trityl-resin by
the standard procedure. Phosphotyrosine was intro-
duced as FmocTyr(PO3Me2)OH (194 mg, 0.3 mmol) in
an analogous fashion. After removal of the terminal
Fmoc group, AcGlyOH (70 mg, 0.6 mmol) was coupled
to the amino-terminus by use of the activation proce-
dure described above. The resin was dried and depro-
tected with TMSBr (1.5 mL, 10 mmol) in TFA/EDT/
TA/TIS (92.5:2.5:2.5:2.5, 10 mL) by incubation for 5 h
under Ar. The peptide library was precipitated with
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diethyl ether, redissolved in NH4HCO3 (0.1 M) and
lyophilized to yield the crude peptide library (123 mg)
as a white solid.
Preparation of Hck SH2 Domain for Non-Covalent
Binding Studies
The Hck SH2 domain (henceforth denoted as M) stock
(9 mg/mL, 2 mM DTT, 0.02% NaN3, Novartis Pharma-
ceuticals, Basel, Switzerland) was desalted on Sephadex
PD10 columns (Pharmacia, Piscataway, NJ) that had
been equilibrated in degassed, ice-cold, deionized wa-
ter. After addition of DTT (1 M in H2O) to a final
concentration of 3 mM, aliquots of the protein were
used immediately or stored at 20 °C.
Non-Covalent Binding of Library to Receptor
The peptide library, Ac-GpYEXX-Eda (0.5 mg, 2 nmole
per single peptide), henceforth denoted as L, was dis-
solved in deionized water and added to 1.6 nmol of
protein to give a final volume of 300 L. The mixture
was incubated at room temperature for 3 h, chilled on
ice and concentrated by MicroCon (St. Louis, MO) 10 to
a final volume of 20 L at 4 °C. The protein/library
mixture was diluted with 150 L H2O. Non-covalent
complex formation was detected at a flow rate of 0.1-1
L/min in a 9.4 T ESI FT-ICR mass spectrometer [28,
29]. Flow rates of 0.3 to 0.5 mL/min were found to be
optimal for the detection of non-covalent complexes
using this instrument, although this varied from day to
day. The parameters of the ESI source and the ion optics
were adjusted for maximum signal for the non-covalent
complex. In general, an octopole accumulation period
of 8 s was found to give the highest signal for the
non-covalent complex.
SWIFT Isolation and Laser-Induced Ligand Release
The multiply-charged ligand:receptor complexes [M 
L  11H], were isolated by the SWIFT technique [21,
22]. A Synrad carbon dioxide IR laser (SYNRAD Inc.,
Mukilteo, WA) beam was used to dissociate each non-
covalent complex to release its bound ligand. The laser
power was high enough to achieve near-complete re-
moval of non-covalent complexes but low enough to
avoid peptide or protein fragmentation.
Immobilization of Hck on a Solid Support
Hck SH2 domain (0.5 mL, 4.5 mg) dissolved in 2 mM
DTT, 0.02% NaN3 was purified over a Sephadex PD10
column that was preequilibrated in sodium phosphate
(100 mM, pH 7). The protein-containing fractions were
combined and immobilized on preactivated agarose
Affi-Gel 10 (BioRad, Hercules, CA) (4 mL) at 4 °C for 5 h
according to the manufacturer’s instructions. A cou-
pling rate of 4 mg Hck SH2 domain per 4 mL gel (67.7
nmol protein/mL gel) was determined by measuring
the free protein in solution based on a Bradford assay
[30]. Excess activated esters were blocked by addition of
ethanolamine (1 M, pH 8, 0.1 mL). The resin was rinsed
thoroughly in sodium phosphate buffer (0.1 M) contain-
ing EDTA (2 mM), DTT (2 mM), and NaN3 (0.02%) and
stored at 4 °C until use. For the negative controls, the
resin was treated as for the protein immobilization
procedure but with ethanolamine (1 M, 0.2 mL) instead
of protein.
Affinity Screening of Hck SH2 Domain
The refrigerated Hck SH2 domain on agarose (100 L)
was washed five times with ice-cold NH4OAc (0.1 M, 1
mL) buffer. The agarose was sedimented by gentle
centrifugation and the supernatant was removed after
each washing step. Ac-GpYEXX-Eda (0.048 mg-0.24 mg,
0.2-1 nmol of each compound) was added to the de-
salted Hck SH2 agarose and made up to a final volume
of 300 L with NH4OAc (0.1 M, pH 7.5). The Hck SH2
domain agarose/library mixture was incubated for 3 h
at room temperature and then chilled on ice. The
incubation mixture was transferred to a MicroPure
Separator (Amicon, Danvers, MA) and centrifuged for
2 s to remove excess solvent. Ice-cold NH4OAc (0.1 M,
pH 7.5) was added to the moist agarose gel and
centrifuged for 2 s as above. This washing step was
performed four times. The wash solutions were col-
lected separately. The tightly bound peptides were
eluted with 4  300 L HCOOH (0.1%) at RT. The
elution fractions were lyophilized, then redissolved in
HCOOH (0.1%)/MeOH (50:50) for ESI FTICR MS anal-
ysis. The negative control was performed analogously
on the deactivated agarose.
CID-Fragmentation of High-Affinity Ligands
The high-affinity ligand solution was infused at a flow
rate of 0.5–3 L/min into an ion trap quadrupole mass
spectrometer (LC-Q, Finnigan, San Jose, CA) equipped
with an ESI-ion source. The ligand ions were isolated
within an m/z window of 1–2 and fragmented by
applying a voltage of 25–30 V depending on the ease of
fragmentation of the individual ions.
Results and Discussion
We recently reported the use of ESI FT-ICR mass
spectrometry as a tool to analyze highly degenerate
libraries of compounds [31], and showed how it can be
applied to the real time monitoring of substrate library
screening by enzymes [11]. However, many biological
processes can be triggered simply by non-covalent
binding of a ligand to a target biomolecule without any
further covalent modification. The gentle ionization
provided by ESI has the potential to allow direct
observation of this non-covalent complex in the gas
phase in a mass spectrometer, and ultimately allow the
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identification of a few preferred ligands from a highly
degenerate combinatorial library. For example, Gao et
al. used ESI FT-ICR MS to determine the components of
a library of 289 sulfonamide-derivatized peptides that
bound most strongly to carbonic anhydrase [12]. Here,
we report the detection and characterization of the
binding specificities of Hck SH2 domain protein to a
compound library of 324 phosphorylated peptides by
ESI FT-ICR mass spectrometry, and compare it to the
results of solution screening.
Non-Covalent Binding
The Hck SH2 domain forms non-covalent complexes
Figure 1, (bottom) with members of a peptide library
having the general sequence, Ac-GpYEXX-Eda. The
library had a maximum of 324 compounds synthesized
by the “mixture coupling” approach. Each component
of the library was acetylated at the N-terminus and
modified by ethylenediamine at the C-terminus. X
represents any of the 20 amino acids except Cys and
Leu. Cys was omitted to exclude the possibility of
disulfide formations, whereas Leu was omitted to avoid
confusion in binding of Ile- versus Leu-containing pep-
tides due to their identical mass.
Comparison of many libraries previously synthe-
sized by this approach with simulated library mass
spectra showed that these peptide libraries were cor-
rectly obtained with expected degeneracy (data not
shown). The preconcentration step reduces the total
salt/library content of the mixture. It may also help
compensate for the slightly different concentrations of
the single compounds in the library caused by different
coupling efficiencies (see below).
As shown in the mass scale-expansion in Figure 1
(top), the multiply-charged non-covalent complex,
[M  L  11H]11, shows a rather broad mass
distribution containing several overlapped non-cova-
lent complexes of Hck SH2 domain with each of several
strongly bound ligands. The identities of these ligands
in the complexes could in principle be obtained from
the accurate masses of the complexes. However, such
Figure 1. Fourier transform ion cyclotron resonance (FT-ICR, 9.4 Tesla) mass spectrum of Hck SH2
domain, electrospray-ionized from a solution containing the complete library, L  Ac-GpYEXX-Eda.
Inset: Mass scale expansion showing resolution of various tightly bound non-covalent complexes
[M  L  11H]11.
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identification is rendered difficult by overlap of the isoto-
pic distributions of different complexes, as well as the
presence of adducts (e.g., Na, K in place of H) which
further broadens each isotopic distribution [7].
Therefore, a simpler means for identifying the
strongly bound ligands was developed. The complexes
of interest were first isolated using the SWIFT technique
[21, 22]. This technique ejects from the Penning ion trap
all ions having m/z different from that of the complex of
interest (Figure 2). The isolated [M  L  11H]11
complexes may then be dissociated by IRMPD by use of
continuous wave (CW) IR laser irradiation. This proce-
dure yields free intact SH2 domain protein, [M 
10H]10, and the ligand(s) released from the complex,
L Figure 3, (bottom). The laser power was adjusted to
achieve maximum dissociation of the non-covalent
complex without fragmentation of the peptides or pro-
tein. The signal intensity of residual complex at this
point was less than 10% of the starting signal intensity.
The mass scale expansion in Figure 3 (top right) shows
the intact free protein, [M  10H]10, whereas Figure
3 (top left) shows the released singly-charged library
molecules with good signal-to-noise ratio and exquisite
mass resolution.
With the Hck SH2 domain, two major peaks (m/z
760.3 and 774.3) were obtained. These species were at
least twice as abundant as any of the other released
Figure 2. FT-ICR mass spectrum of SWIFT-isolated multiply-
charged non-covalent complexes, [M  L  11H]11, between
Hck SH2 domain and members of the peptide ligand library, L 
Ac-GpYEXX-Eda. Note that the expanded spectrum looks the
same as in Figure 1.
Figure 3. FT-ICR mass spectrum following infrared multiphoton dissociation of tightly-bound
non-covalent complexes, [M  L  11H]11, to yield free Hck SH2 domain (10 charge state) and
its (singly-charged) ligands. The insets show mass scale-expanded segments for the released ligands
(upper left) and the isotopically resolved free protein [M  10H]11 (upper right). The two major
peaks correspond to the peptides, Ac-GpYEXX-Eda, in which XX  DI/EV or EI, respectively.
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library components. They were assigned by their mass
to two of the library components, pYEDI/pYEEV and
pYEEI, respectively. The latter is known to be the
highest affinity binding sequence for the Src SH2 do-
main [15], a close evolutionary relative of the Hck SH2
domain. In these studies the binding motif pYE(E,
D)(I,V,M) was identified for the closest relative to Hck
SH2, the Lck SH2 domain. Due to the relatively small
number of released ligand ions, further IRMPD frag-
mentation of these ligands was not attempted.
Affinity Screening
To compare the results obtained by the mass spectro-
metric method with those obtained from a conventional
library screening protocol, the 324-compound library
Ac-GpYEXX-Eda 1 (0.1 nmol for each compound) was
presented to Hck SH2 domain immobilized onto aga-
rose. The affinity screening of Hck SH2 on agarose-
support allows for fast removal of excess library (10 s)
with minimal loss of tight-binding ligands, something
of concern given the short half lives of the complexes
between other SH2 domains and their preferred peptide
ligand [32]. An agarose support was chosen for its
hydrophilicity, which minimizes protein distortions
and lowers the amount of non-specific binding. After a
wash with ice-cold buffer to remove excess library and
low affinity ligands, high-affinity ligands were eluted
with 0.1% formic acid. The final acid elution showed
10 distinct mass spectral peaks. Two independent
screenings showed the same mass spectral peaks from
the final elution. The peak magnitudes of the acid-
elutions in both experiments did not deviate more than
10%. The elution fractions were lyophilized, redis-
solved, and analyzed by ESI FTICR MS (4.7 T). The
mass spectra of the first washing solution (which rep-
resents the excess unbound library) and the final elution
fraction are illustrated in Figure 4 (top and middle),
respectively.
A negative control with deactivated Affi-Gel 10 was
performed analogously. The deactivated agarose gel
was obtained by quenching activated ester positions
with excess ethanolamine during the coupling. The
acid-elution of the negative control Figure 4, (bottom)
shows two major peaks that corresponded to two major
peaks in the Hck SH2 domain screening. The slightly
higher masses already indicated the non-peptidic origin
of these mass peaks, as later confirmed by CID frag-
mentation. Non-peptidic contaminants as identified via
CID-fragmentation are marked with an asterisk.
All ions generating a signal of sufficient magnitude
were subjected to CID fragmentation. Due to low ligand
concentration, the amino acid sequence determination
was performed with an LC-Q ion trap mass spectrom-
eter that allows CID fragmentation of multiple ions in a
short period of time. The same tight-binding ligands
were identified in a solution screening assay by use of
ultrafiltration devices (MicroCon 10) (data not shown).
The results of CID fragmentation are summarized in
Table 1.
The elucidated sequences reveal two major amino
acid binding motifs for Hck SH2 domain. The first had
a phosphotyrosine followed by a glutamate, and then
two hydrophobic residues. Isoleucine and valine were
preferred as the hydrophobic amino acids in the pY  3
position. The second motif had a phosphotyrosine fol-
lowed by a glutamate, followed by either a glutamate or
Figure 4. FT-ICR mass spectra (4.7 tesla), showing resolution of
unbound (top) and tightly-bound (bottom) Ac-GpYEXX-Eda li-
gands in the affinity-screening by immobilized Hck SH2 domain.
Top: First elution of unbound and loosely bound library ligands.
Middle: Final acid elution of tightly-bound ligands. Bottom: Final
acid elution of the negative control (asterisk denotes artifact
peaks).
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an aspartate, followed by either an isoleucine or a
valine. The second motif corresponds directly to the
sequence identified from the non-covalent binding
studies in the gas phase, and is consistent with the
expectation based on the close evolutionary relation-
ship between Hck, Lck, and Src SH2 domains.
The observation of tight binding amino acid motifs
carrying a hydrophobic amino acid at the pY  2
position is consistent with results of studies in solution
reported by Payne et al. [33]. In these studies, replace-
ment of Glu at pY  2 with hydrophobic amino acids
such as Ile resulted in negligibly different binding
constants to Lck. In the crystal structure of Hck SH2
domain, the pY  2 residue projects away from the
protein toward the solvent and therefore plays a less
important role for the binding.
Our inability to observe the binding motif pY-E-
hydrophobic-hydrophobic during the non-covalent
binding studies in the gas phase matches recent results
by Smith and coworkers, who quantitated and com-
pared gas phase stabilities of carbonic anhydrase com-
plexed with some of its known inhibitors with hydro-
phobicity and the calculated polar surface areas of these
selected ligands [13]. Their comparison indicated that
polar interactions are the dominating forces for pro-
tein/ligand interactions in the gas phase, whereas hy-
drophobic interactions determine the binding strength
in solution. As a consequence, hydrophobic ligand
receptor interactions are less likely to be observed in the
gas phase, consistent with the results reported here.
Last, we must consider the possibility that the solid
phase peptide synthesis generated a library that was
very biased, that different peptides were represented in
very different amounts, and that the peptides identified
in this experiment were simply those present in large
amounts in the original library. Several observations
make this less than likely. First, the spectrum of the
peptide library itself shows no large differences in
peptides present in the mixture, and no evidence for
dramatically different detection of different peptides in
the mixture. If the peptides identified in the experiment
were simply the compounds that had the highest con-
centrations in the library, then one would expect an
intense mass peak at the corresponding m/z of the mass
spectrum of the peptide mixture. No such peak is seen
(see the lower mass region of Figure 1). To rule out very
different detection mass spectrum detection responses,
we simulated the ion mass distribution in the library
(assuming equal coupling efficiencies in the peptide syn-
thesis), and compared it to the actual distribution of
masses in the MS of the peptide library. The two corre-
sponded closely, indicating both that the distribution of
peptides in the mixture was not very different from that
expected with equal coupling efficiencies, and that the
detectability of different peptides was nearly uniform.
One way to have a “less preferred” peptide emerge
from this experiment is if its total stoichiometry is less
than the stoichiometry of the receptor. The preconcen-
tration step, in addition to removing salt, ensured that
even if the peptide was inefficiently synthesized
(present at only 10% of the concentration of the average
peptide), then it would still be present in sufficient
stoichiometric amounts to saturate the receptor.
Conclusion
The results reported here illustrate the range of biolog-
ical questions relating to protein ligand interactions that
might be addressed by combining ESI, FT-ICR MS,
SWIFT, and IRMPD [34]. Although we observed dis-
crimination against hydrophobic interactions in trans-
ferring the non-covalent receptor/ligand complexes
from solution to the gas phase, the gas phase screening
technique allowed the identification of the same high
affinity ligands as far as polar ligands are concerned.
Moreover, the speed and simplicity of the mass spec-
trometric non-covalent binding assay makes it prefera-
ble to solution methods for efficient screening of large
combinatorial libraries. Only 1–2 nmol of protein are
needed for an experiment. No preparative isolation of
the protein/ligand complex is required. The analysis
can be done under quasi-physiological conditions, di-
rectly from the incubated protein/library mixture. Fi-
nally, CID fragmentation of ligands released and iso-
lated in the gas phase can unequivocally establish the
chemical structure of each preferred ligand. Thus, incu-
bation, selection, and structure determination can effec-
tively be done in a single analysis.
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714.47 Daa b Non-peptidic contaminant
719.41 d Non-peptidic contaminant
730.31  -V-V-
735.40  Non-peptidic contaminant
744.34 c -V-I-(65%); -I-V-(35%)
758.35  -I-I
760.29  -D-I-(50%); -E-V-(50%)
774.30  -E-I-
778.31  -F-V-
792.34  -F-I-(70%); -I-F-(30%)




1168 WIGGER ET AL. J Am Soc Mass Spectrom 2002, 13, 1162–1169
References
1. Shevchenko, A.; Jensen, O. N.; Podtelejnikov, A. V.; Sagliocco,
F.; Wilm, M.; Vorm, O.; Mortensen, P.; Shevchenko, A.;
Boucherie, H.; Mann, M. Linking Genome and Proteome by
Mass Spectrometry: Large-Scale Identification of Yeast Pro-
teins from Two Dimensional Gels. Proc. Nat. Acad. Sci. U.S.A.
1996, 93, 14440–14445.
2. Link, A. J.; Hays, L. G.; Carmack, E. B.; Yates, J. R. Identifying
the Major Proteome Components of Haemophilus influenzae
Type Strain NCTC 8143. Electrophoresis 1997, 8, 1314–1334.
3. Marshall, A. G.; Hendrickson, C. L.; Jackson, G. S. Fourier
Transform Ion Cyclotron Resonance Mass Spectrometry: A
primer. Mass Spectrom. Rev. 1998, 17, 1–35.
4. Fenn, J. B.; Mann, M.; Meng, C. K.; Wong, S. F. Electrospray
Ionization—Principles and Practice. Mass Spectrom. Rev. 1990,
9, 37–70.
5. Karas, M.; Hillenkamp, F. Laser Desorption Ionization of
Proteins with Molecular Masses Exceeding 10,000 daltons.
Anal. Chem. 1988, 60, 2301–2303.
6. Smith, R. D.; Bruce, J. E.; Wu, Q.; Lei, Q. P. New Mass
Spectrometric Methods for the Study of Noncovalent Associ-
ations of Biopolymers. Chem. Soc. Rev. 1997, 26, 191–202.
7. Loo, J. A.; Hu, P. F.; McConnell, P.; Mueller, W. T.; Sawyer,
T. K.; Thanabal, V. A Study of Src SH2 Domain Protein-
Phosphopeptide Binding Interactions by Electrospray Ioniza-
tion Mass Spectrometry. J. Am. Soc. Mass Spectrom. 1997, 8,
234–243.
8. Wood, T. D.; Chorush, R. A.; Wampler, F. M.; Little, D. P.;
O’Connor, P. B.; McLafferty, F. W. Gas-Phase Folding and
Unfolding of Cytochrome-C Cations. Proc. Nat. Acad. Sci.
U.S.A. 1995, 92, 2451–2454.
9. Anderegg, R. J.; Wagner, D. S. Mass-Spectrometric Character-
ization of a Protein Ligand Interaction. J. Am. Chem. Soc. 1995,
117, 1374–1377.
10. Smith, R. D.; Loo, J. A.; Edmonds, C. G.; Barinaga, C. J.;
Udseth, H. R. NEW Developments in Biochemical Mass-Spec-
trometry-Electrospray Ionization. Anal. Chem. 1990, 62, 882–
899.
11. Wigger, M.; Nawrocki, J. P.; Watson, C. H.; Eyler, J. R.; Benner,
S. A. Assessing Enzyme Substrate Specificity Using Combina-
torial Libraries and Electrospray Ionization Fourier Transform
Ion Cyclotron Resonance Mass Spectrometry. Rapid Commun.
Mass Spectrom. 1997, 11, 1749–1752.
12. Gao, J.; Cheng, X.; Chen, R.; Sigal, G. B.; Bruce, J. E.; Schwartz,
B. L.; Hofstadler, S. A.; Anderson, G. A.; Smith, R. D.;
Whitesides, G. M. Screening Derivatized Peptide Libraries for
Tight Binding Inhibitors to Carbonic Anhydrase II by Electro-
spray Ionization Mass Spectrometry. J. Med. Chem. 1996, 39,
1949–1955.
13. Wu, Q.; Gao, J.; Joseph-McCarthy, D.; Sigal, G. B.; Bruce, J. E.;
Whitesides, G. M.; Smith, R. D. Carbonic Anhydrase-Inhibitor
Binding: From Solution to the Gas Phase. J. Am. Chem. Soc.
1997, 119, 1157–1158.
14. Koch, C. A.; Anderson, D.; Moran, M. F.; Ellis, C.; Pawson, T.
SH2 and SH3 Domains—Elements that control interactions of
cytoplasmic signaling proteins. Science 1991, 252, 668–674.
15. Songyang, Z.; Shoelson, S. E.; Chaudhuri, M.; Gish, G.; Paw-
son, T.; Haser, W. G.; King, F.; Roberts, T.; Ratnofsky, S.;
Lechleider, R. J.; Neel, B. G.; Birge, R. B.; Fajardo, J. E.; Chou,
M. M.; Hanafusa, H.; Schaffhausen, B.; Cantley, L. C. SH2
Domains Recognize Specific Phosphopeptide Sequences. Cell
1993, 72, 767–778.
16. Songyang, Z.; Shoelson, S. E.; Mcclade, J.; Olivier, P.; Pawson,
T.; Bustelo, X. R.; Barbacid, M.; Sabe, H.; Hanafusa, H.; Yi, T.;
Ren, R.; Baltimore, D.; Ratnofsky, S.; Feldman, R. A.; Cantley,
L. C. Specific Motifs Recognized by the SH2 Domains of CSK,
3BP2, FPS FES, GRB-2, HCP, SHC, SYK, and VAV. Mol. Cell.
Biol. 1994, 14, 2777–2785.
17. Quintrell, N.; Lebo, R.; Varmus, H.; Bishop, J. M.; Pettenati,
M. J.; Lebeau, M. M.; Diaz, M. O.; Rowley, J. D. Identification
of a Human-Gene (hck) that Encodes a Protein-Tyrosine
Kinase and is Expressed in Hematopoietic Cells. Mol. Cell. Biol.
1987, 7, 2267–2275.
18. Ziegler, S. F.; March, J. D.; Lewis, D. B.; Perlmutter, R. M.
Novel Protein-Tyrosine Kinase Gene (hck) Preferentially Ex-
pressed in Cells of Hematopoietic Origin. Mol. Cell. Biol. 1987,
7, 2276–2285.
19. Sicheri, F.; Moarefi, I.; Kuriyan, J. Crystal Structure of the Src
Family Tyrosine Kinase Hck. Nature 1997, 385, 602–609.
20. Moarefi, I.; LaFevre-Bernt, M.; Sicheri, F.; Huse, M.; Lee, C. H.;
Kuriyan, J.; Miller, W. T. Activation of the Src-Family Tyrosine
Kinase Hck by SH3 Domain Displacement. Nature 1997, 385,
650–653.
21. Marshall, A. G.; Wang, T. C. L.; Ricca, T. L. Tailored Excitation
for Fourier-Transform Ion-Cyclotron Resonance Mass Spectro-
metry. J. Am. Chem. Soc. 1985, 107, 7893–7897.
22. Guan, S. H.; Marshall, A. G. Stored Waveform Inverse Fourier
Transform (SWIFT) Ion Excitation in Trapped-Ion Mass Specto-
metry: Theory and Applications. Int. J. Mass Spect. 1996, 158,
5–37.
23. Atherton, E.; Gait, M. J.; Sheppard, R. C.; Williams, B. Poly-
amide Method of Solid-Phase Peptide and Oligonucleotide
Synthesis. J. Bioorg. Chem. 1979, 8, 351–370.
24. Knorr, R.; Trzeciak, A.; Bannwarth, W.; Gillessen, D. New
Coupling Reagents in Peptide Chemistry. Tetrahed. Lett. 1989,
30, 1927–1930.
25. Ko¨nig, W; Geiger, R. N-Hydroxyverbindungen als Katalysa-
toren fu¨r die Aminolyse aktivierter Ester. Chem. Ber 1970, 103,
2034–2040.
26. Carpino, L. A.; Han, G. Y. 9-Fluorenylmethoxycarbonyl Ami-
no-Protecting Group. J. Org. Chem. 1973, 37, 3404–3409.
27. Kramer, A.; Volkmer-Engert, R.; Malin, R.; Reineke, U. Schnei-
der-Mergener J. Simultaneous Synthesis of Peptide Libraries
on Single Resin and Continuous Cellulose Membrane Sup-
ports—examples for the Identification of Protein, Metal, and
DNA-Binding Peptide Mixtures. J. Pept. Res. 1993, 6, 314–319.
28. Senko, M. W.; Hendrickson, C. L.; Pasa-Tolic, L.; Marto, J. A.;
White, F. M.; Guan, S.; Marshall, A. G. Electrospray Ionization
Fourier Transform Ion Cyclotron Resonance at 9.4 T. Rapid
Commun. Mass Spectrom. 1996, 10, 1824–1828.
29. Senko, M. W.; Hendrickson, C. L.; Emmett, M. R.; Shi, S. D. H.;
Marshall, A. G. External Accumulation of Ions for Enhanced
Electrospray Ionization Fourier Transform Ion Cyclotron Res-
onance Mass Spectrometry. J. Am. Soc. Mass Spectrom. 1997, 8,
970–976.
30. Bradford, M. M. Rapid and Sensitive Method for Quantitation
of Microgram Quantities of Protein Utilizing Principle of
Protein-Dye Binding. Anal. Biochem. 1976, 72, 248–254.
31. Nawrocki, J. P.; Wigger, M.; Watson, C. H.; Hayes, T. W.;
Senko, M. W.; Benner, S. A.; Eyler, J. R. Analysis of Combina-
torial Libraries Using Electrospray Fourier Transform Ion
Cyclotron Rresonance Mass Spectrometry. Rapid Commun.
Mass Spectrom. 1996, 10, 1860–1864.
32. Botfield, M. C.; Green, J. SH2 and SH3 Domains: Choreogra-
phers of Multiple Signaling Pathways. Ann. Rep. Med. Chem.
1995, 30, 227–238.
33. Payne, G.; Stolz, L. A.; Pei, D.; Band, H.; Shoelson, S. E.; Walsh,
C. T. The Phosphopeptide-Binding Specificity of Src Family
SH2 Domains. Chem. Biol. 1994, 1, 99–105.
34. Hernandez, H; Robinson, C. V. Dynamic Protein Complexes:
Insights from Mass Spectrometry. J. Biol. Chem. 2001, 276,
46685–46688.
1169J Am Soc Mass Spectrom 2002, 13, 1162–1169 IDENTIFICATION AND SCREENING OF Hck Src DOMAIN
